Grantham, Mayo, Van Otterloo & Co (GMO)’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.4M Buy
134,525
+75,834
+129% +$16.4M 0.07% 135
2026
Q1
$12.2M Buy
+58,691
New +$10.8M 0.03% 232
2018
Q2
Sell
-8,300
Closed -$746K 611
2018
Q1
$746K Hold
8,300
﹤0.01% 409
2017
Q4
$733K Buy
+8,300
New +$746K ﹤0.01% 390

Other funds holding SLAB

Grantham, Mayo, Van Otterloo & Co (GMO)'s SLAB Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Silicon Laboratories (SLAB) stake by 129% in Q2 2026, buying an estimated $16.4M and bringing the position to 134,525 shares worth $29.4M. The position accounts for 0.07% of the portfolio, ranked #135.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SLAB in Q4 2017 and has held it in 4 quarters since. 352 funds tracked by Wall St. Rank hold SLAB as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 134,525 shares of Silicon Laboratories worth $29.4M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 75,834 Silicon Laboratories shares in Q2 2026, an estimated $16.4M.
  • Silicon Laboratories made up 0.07% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #135 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Silicon Laboratories in Q4 2017 and has held it in 4 quarters since.
  • 352 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.